top of page

Mwandishi

Mhariri:

ULY CLINIC

Dkt. Benjamin L, MD

18 Machi 2021, 18:26:39

Ampicillin na ujauzito

Ampicillin na ujauzito

Dawa jamii ya penicillin huchukuliwa kama dawa zenye hatari kidogo kipindi chochote kile katika ujauzito. Uchunguzi huu unawezekana kuwa haujarekebishwa kwa dawa jamii ya aminopenicillins kama ampicillin na Amoxicillin kwa sababu kuna ushahidi kuwa kutumia dawa hizi kipindic ha kwanza cha ujauzito huongeza hatari ya madhaifu ya kiuumbaji kwa watoto wanaozaliwa na mama aliyetumia dawa hii kama mdomo sungura. Hata hivyo kihatarishi huwa ni kidogo na mahusiano haya yanatakiwa kufanyiwa uchunguzi.


Ushauri dhidi ya matumizi kwa mama mjamzito


Taarifa za binadamu zinaonyesha hatari kwenye kipindi cha kwanza cha ujauzito


Taarifa za binadamu zinaonyesha hatari kwenye kipindi cha kwanza cha ujauzito ina maana gani?

Ushahidi wa dawa hii au dawa zingine zinazofanana nah ii unaonyesha kuwepo kwa hatari ya kuleta sumu kwenye uumbaji wa kichanga tumboni kwa na kusababisha madhaifu ya uumbaji, ukuaji, viungo vya mwili, ufanyaji kazi wa viungo, tabia au kusababisha kifo cha kichanga au kijusi tumboni katika kipindi cha kwanza tu na sio kipindi cha pili au tatu. Taarifa za madhara ya dawa hii kwa binadamu zinamashiko zaidi kuliko taarifa za tafiti kwa wanyama.


Ushauri wa matumizi kwa mama anayenyonyesha


Inapatana na unyonyeshaji


Inapatana na unyonyeshaji ina maanisha nini?

Kiasi kidogo cha dawa hii kinawezekana kuingia kwenye maziwa ya mama, kiasi hiki hakina mashiko ya kusababisha sumu kwa kichanga anayenyonya. Dawa hii haitarajiwi kusababisha madhara kwa kichanga anayenyonya maziwa ya mama anayetumia dawa hii.

ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha  vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.

Imeboreshwa,

4 Juni 2025, 19:03:28

​

  1. Bray R, Boc R, Johnson W. Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy. Am J Obstet Gynecol. 1966;96:938–42.

  2. MacAulay M, Abou-Sabe M, Charles D. Placental transfer of ampicillin. Am J Obstet Gynecol. 1966;96:943–50.

  3. Biro L, Ivan E, Elek E, Arr M. Data on the tissue concentration of antibiotics in man. Tissue concentrations of semi-synthetic penicillins in the fetus. Int Z Klin Pharmakol Ther Toxikol. 1970;4:321–4.

  4. Elek E, Ivan E, Arr M. Passage of penicillins from mother to foetus in humans. Int J Clin Pharmacol Ther Toxicol. 1972;6:223–8.

  5. Kraybill EN, Chaney NE, McCarthy LR. Transplacental ampicillin: inhibitory concentrations in neonatal serum. Am J Obstet Gynecol. 1980;138:793–6.

  6. Jordheim O, Hagen AG. Study of ampicillin levels in maternal serum, umbilical cord serum and amniotic fluid following administration of pivampicillin. Acta Obstet Gynecol Scand. 1980;59:315–7.

  7. Philipson A. Pharmacokinetics of ampicillin during pregnancy. J Infect Dis. 1977;136:370–6.

  8. Noschel VH, Peiker G, Schroder S, Meinhold P, Muller B. Untersuchungen zur pharmakokinetik von antibiotika und sulfanilamiden in der schwangerschaft und unter der geburt. Zentralbl Gynakol. 1982;104:1514–8.

  9. Willman K, Pulkkinen M. Reduced maternal plasma and urinary estriol during ampicillin treatment. Am J Obstet Gynecol. 1971;109:893–6.

  10. Boehn F, DiPietro D, Goss D. The effect of ampicillin administration on urinary estriol and serum estradiol in the normal pregnant patient. Am J Obstet Gynecol. 1974;119:98–101.

  11. Sybulski S, Maughan G. Effect of ampicillin administration on estradiol, estriol and cortisol levels in maternal plasma and on estriol levels in urine. Am J Obstet Gynecol. 1976;124:379–81.

  12. Aldercreutz H, Martin F, Lehtinen T, Tikkanen M, Pulkkinen M. Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. Am J Obstet Gynecol. 1977;128:266–71.

  13. Van Look PFA, Top-Huisman M, Gnodde HP. Effect of ampicillin or amoxycillin administration on plasma and urinary estrogen levels during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1981;12:225–33.

  14. Dossetor J. Drug interactions with oral contraceptives. Br Med J. 1975;4:467–8.

  15. DeSano EA Jr, Hurley SC. Possible interactions of antihistamines and antibiotics with oral contraceptive effectiveness. Fertil Steril. 1982;37:853–4.

  16. Friedman CI, Huneke AL, Kim MH, Powell J. The effect of ampicillin on oral contraceptive effectiveness. Obstet Gynecol. 1980;55:33–7.

  17. Back DJ, Breckenridge AM, MacIver M, Orme M, Rowe PH, Staiger C, Thomas E, Tjia J. The effects of ampicillin on oral contraceptive steroids in women. Br J Clin Pharmacol. 1982;14:43–8.

  18. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol. 1979;109:433–9.

  19. Zierler S. Maternal drugs and congenital heart disease. Obstet Gynecol. 1985;65:155–65.

  20. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1977.

  21. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665–9.

  22. Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol. 1988;159:539–43.

  23. Morales WJ, Angel JL, O’Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol. 1989;73:721–6.

  24. Heim K, Alge A, Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet. 1991;337:859.

  25. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol. 2001;185:140–7.

  26. Wilson J, Brown R, Cherek D, Dailey JW, Hilman B, Jobe PC, Manno BR, Manno JE, Redetzki HM, Stewart JJ. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet. 1980;5:1–66.

  27. Knowles J. Excretion of drugs in milk—a review. J Pediatr. 1965;66:1068–82.

  28. Williams M. Excretion of drugs in milk. Pharm J. 1976;217:219.

  29. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;168:1393–9.

bottom of page